Reviewed by Jay S. Duker, MD Positive safety results from the Phase 1 DAVIO clinical trial were obtained for the DuraSert implant (EYP-1901, Vorolanib, EyePoint Pharma), a bioerodible implant for previously treated wet age-related macular degeneration (AMD), according to Jay S. Duker, MD, Chief Operating Officer, who presented the 8-month results at the Angiogenesis, Exudation, … Read more
A. Paul Chous, MA, OD, FAAO: How do you rate the current treatment landscape for retinal diseases? Where do you think it is? Where do you think we’re going? Dilsher S. Dhoot, MD: I think we’ve made a lot of progress. If you think back to 2006 when we first used anti-VEGF agents for wet … Read more
As people get into their 40s and beyond, their near vision begins to deteriorate. For many people, increasing the font size on a phone or maximizing the brightness on a computer is the only way to read text. This condition is known as presbyopia and affects approximately 128 million people in the US and more … Read more
Researchers have found that a decrease in retinal vessel density could be associated with moderate or severe cases of pneumonia in patients diagnosed with COVID-19. Miguel Ángel Zapata, MD, from the Ophthalmology Service, Vall d’Hebron University Hospital, Barcelona, Spain, and colleagues from several Spanish institutions, identified a retinal effect of COVID-19, meaning that patients with … Read more
A. Paul Chous, MA, OD, FAAO: We move on to another topic. We were asked to consider the American Academy of Ophthalmology guidelines for patient co-management. I wonder about your thoughts. To what extent does this apply to the relationship between non-surgical providers, i.e. optometrists and retinal specialists? Is it valid? Do we work well … Read more
Publisher’s Note: the times of ophthalmology® Research Scholar Honoree Program is dedicated to educating fellows and residents of the retina by providing a unique opportunity for fellows and residents to share remarkable research and challenging cases with their peers and mentors. The program is supported by an unrestricted grant from Regeneron Pharmaceuticals. special to Ophthalmology … Read more
The much-anticipated EURETINA 2021 virtual meeting, scheduled for 9-12 September 2021, is fast approaching and should prove to be as great an educational opportunity as last year’s conference to engage with the latest scientific developments. EURETINA President Frank G. Holz, MD, FEBO, FARVO, reported that this year’s meeting will be structured similarly to 2020 and … Read more
A 20-year-old man presented to the hospital complaining of a persistent afterimage affecting his right eye following a laser exposure approximately 20 minutes previously. The symptom had not gone away in the time since the incident. According to the patient, he and a lab colleague played laser tag without permission. The patient also mentioned that … Read more
Publisher’s Note: the Ophthalmology Times® The Research Scholar Honoree Program is dedicated to educating fellows and residents of the retina by providing fellows and residents with a unique opportunity to share remarkable research and challenging cases with their peers and mentors. The program is supported by an unrestricted grant from Regeneron Pharmaceuticals.Despite successful repair of … Read more
John W. Kitchens, MD: Roger, both Dante and Lloyd mentioned this wet age-related or exudative age-related macular degeneration. Can you describe that to us? Roger A Goldberg, MD, MBA: Yes. As Lloyd mentioned, there are 2 advanced forms of age-related macular degeneration. There’s the advanced dry form that we call geographic atrophy, which is not … Read more